The Feinstein Institute of Behavioral Science: Research and Innovation [Video]

The Institute of Behavioral Science (IBS) at Northwell Health in NYC is a research powerhouse, tackling major psychiatric disorders like schizophrenia, bipolar disorder, depression, and addiction. With a team of 15 principal investigators and a total staff of 100, the IBS is at the forefront of understanding the intricacies of the human mind.
What sets the IBS apart is its unique blend of resources. A strong clinical operation serves as the backbone for their research endeavors, allowing them to conduct impactful clinical trials. They are also pioneers in utilizing brain imaging, specifically MRI, to unravel the workings of these disorders and assess treatment efficacy.
Being situated in the diverse community of Queens gives the IBS the upper hand in studying the complex interplay of biological and environmental factors that influence mental health. This diverse patient population is readily accessible thanks to the institute’s location within the Zucker Hillside Hospital, promoting seamless collaboration between researchers and clinicians.
The IBS doesn’t just focus on research; it fosters a nurturing environment where young investigators thrive under the guidance of experienced mentors. This emphasis on mentorship ensures the continued growth and innovation in the field of psychiatric research. Support from the National Institutes of Health and private foundations further empowers the IBS to pursue groundbreaking research initiatives.
Through its unwavering dedication to research, technology, and patient care, the Institute of Behavioral Science is paving the way for a future where mental illness is better understood and effectively treated.